COMMUNIQUÉS West-GlobeNewswire
-
Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
19/04/2018 - 03:00 -
Health Point Productions' Gene Wilder Bio-Documentary Moving Forward
18/04/2018 - 23:25 -
National Research Corporation to Broadcast its 2018 First Quarter Conference Call Live on the Internet
18/04/2018 - 23:00 -
LeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018
18/04/2018 - 22:35 -
Parliamentary report echoes nurses’ twenty-year call for universal pharmacare
18/04/2018 - 22:28 -
Un rapport de la Chambre des communes fait écho aux infirmières et infirmiers qui demandent depuis vingt ans un régime universel d’assurance-médicaments
18/04/2018 - 22:28 -
Flexion Therapeutics Announces Publication of Results from Pivotal Phase 3 Study of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) in the Journal of Bone and Joint Surgery
18/04/2018 - 22:20 -
Qu Biologics Begins Phase 2 Clinical Trial in Crohn’s Disease
18/04/2018 - 22:16 -
CohBar, Inc. Announces Voluntary Delisting from the TSX Venture Exchange
18/04/2018 - 22:05 -
Sandoz signs agreement with Pear Therapeutics to develop and commercialize prescription digital therapeutics for patients with substance use disorder and opioid use disorders
18/04/2018 - 22:02 -
Pre-Clinical Data Demonstrating Promising Potential of Prexigebersen as Treatment for Solid Tumors in Gynecologic Malignancies Presented at American Association for Cancer Research Annual Meeting
18/04/2018 - 22:01 -
Krystal Biotech Presents Their Skin TARgeted Delivery Platform at the World Orphan Drug Congress USA
18/04/2018 - 22:01 -
Sientra Receives FDA Approval of PMA Supplement
18/04/2018 - 22:01 -
Paratek Pharmaceuticals, Inc. Announces Proposed Private Offering of $125 Million of Convertible Senior Subordinated Notes due 2024
18/04/2018 - 22:01 -
CAPS® Experts & Quality Assurance Programs to be Featured at NHIA 2018
18/04/2018 - 21:48 -
Terveystalo Plc recognizes deferred tax assets with a positive, one-time net result impact of approximately EUR 13 million in the first quarter of 2018
18/04/2018 - 21:01 -
NeuroMetrix to Present Data on Quell Sleep Monitoring Technology at Upcoming American Academy of Neurology Annual Meeting
18/04/2018 - 20:00 -
Cambridge Innovation Institute Announces the Acquisition of the AI World Conference & Expo and AI Trends
18/04/2018 - 19:00 -
21st Century Oncology Appoints Chief Executive Officer – Kimberly Commins-Tzoumakas
18/04/2018 - 18:44
Pages